Rossari Biotech - A Formulation And Application Specialists: ICICI Securities Initiates Coverage
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Rossari Biotech Ltd. has competency in four chemistries used for textile chemicals, but it has successfully applied its learnings into the new industries of home care, personal care and performance chemicals, which has expanded its addressable market multifold.
This was done without compromising on margins, balance sheet or return on invested capital (which remains the best among peers).
The company is likely to have expanded its capacity more than two times by FY21-end, which provides strong earnings visibility.
Revenue and net profit are estimated to grow at compound annual growth rate of 22% and 26% over FY20-FY23E.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.